Aqilion
is a Sweden-based biotechnology company that researches and develops novel therapies for the treatment of chronic inflammatory diseases... Read moreAqilion
is a Sweden-based biotechnology company that researches and develops novel therapies for the treatment of chronic inflammatory diseases... Read more
News
Jun 18, 2026
Cision
Press Release: Aqilion : Resolutions from AQILION AB (publ) Annual General Meeting 2026
Mar 20, 2026
Cision
Press Release: Aqilion : Aqilion to Present Preclinical Data at Digestive Disease Week, May 2-5, Demonstrating That AQ280 Counteracts Dysfunctional Epithelial Barrier Function in Eosinophilic Esophagitis
Oct 22, 2025
PMLiVE
Aqilion: Aqilion announces positive results from eosinophilic esophagitis treatment study
Jun 05, 2025
Cision
Press Release: Aqilion : Aqilion Presents New Preclinical Proof-of-Concept Data for TAK1 Program
Jun 03, 2025
Cision
Press Release: Aqilion : Resolutions from AQILION AB (publ) Annual General Meeting 2025
May 12, 2025
Cision
Press Release: Aqilion : Aqilion receives IND approval from FDA
May 06, 2025
Cision
Press Release: Aqilion : Aqilion publishes Annual Report for 2024
Apr 04, 2025
Cision
Press Release: Aqilion : Aqilion presents results from study of biomarkers in patients with Eosinophilic esophagitis (EoE) at the Digestive Disease Week conference on May 3-6
Apr 02, 2025
Cision
Press Release: Aqilion : Aqilion announces final outcome of rights issue
Mar 12, 2025
Cision
Press Release: Aqilion : Aqilion extends period for subscription of ongoing rights rights issue